MDxHealth (MDXH) EBITDA Margin (2021 - 2026)
MDxHealth's (MDXH) quarterly EBITDA Margin came in at 15.84% in Q1 2026, down 1036.0% year-on-year from 1.69% in Q1 2025, and down 121.64% quarter-over-quarter from 7.15% in Q4 2025.
MDxHealth (MDXH) EBITDA Margin (2021 - 2026) Analysis & Trends
MDxHealth has disclosed EBITDA Margin across 6 years of filings, most recently posting 15.84% for Q1 2026.
- EBITDA Margin for Q1 2026 came in at 15.84%, down 1036.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.01% (up 1213.0% YoY), and the FY2025 annual result was 1.05%, up 1524.0% from the prior year.
- EBITDA Margin came in at 15.84% for Q1 2026 at MDxHealth, down from 7.15% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 287347.56% in Q2 2022 to a low of 130.02% in Q1 2022.
- The 5-year median for EBITDA Margin is 16.59% (2024), against an average of 26095.68%.
- Across the five-year window, EBITDA Margin slumped 28741392 bps in 2023 and soared 5483 bps in 2024, its largest moves.
- MDxHealth's EBITDA Margin stood at 69.41% in 2022, then surged by 68 bps to 22.53% in 2023, then surged by 75 bps to 5.57% in 2024, then retreated by 28 bps to 7.15% in 2025, then tumbled by 122 bps to 15.84% in 2026.
- The last three EBITDA Margin figures came in at 15.84% (Q1 2026), 7.15% (Q4 2025), and 3.47% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -3.71% |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 16.93% |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 22.58% |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 31.78% |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 21.74% |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | -12.21% |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 12.38% |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 19.16% |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 19.42% |
| 10 | MDxHealth | 6,270.00 | -43.15 Mn | 16.61 Mn | -15.84% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.84% |
| Dec 31, 2025 | -7.15% |
| Sep 30, 2025 | 3.47% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | -5.48% |
| Dec 31, 2024 | -5.57% |
| Sep 30, 2024 | -16.59% |
| Jun 30, 2024 | -22.06% |
| Mar 31, 2024 | -22.87% |
| Dec 31, 2023 | -22.53% |
| Sep 30, 2023 | -23.57% |
| Jun 30, 2023 | -66.36% |
| Mar 31, 2023 | -77.70% |
| Dec 31, 2022 | -69.41% |
| Sep 30, 2022 | 156,760.69% |
| Jun 30, 2022 | 287,347.56% |
| Mar 31, 2022 | -130.02% |
| Dec 31, 2021 | -120.52% |
| Sep 30, 2021 | 239,421.35% |